Stocks and Investing Stocks and Investing
Fri, July 25, 2014
Thu, July 24, 2014

Christopher Marai Maintained (BIIB) at Strong Buy with Increased Target to $424 on, Jul 24th, 2014


Published on 2024-10-25 05:33:20 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Maintained "Biogen Inc." (BIIB) at Strong Buy with Increased Target from $415 to $424 on, Jul 24th, 2014.

Christopher has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Cory Kasimov of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $375 on, Thursday, May 29th, 2014
  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $395 on, Thursday, March 27th, 2014

Contributing Sources